Delivery Order SPE2DB22D2206-SPE2DB25FKA93
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,258.15 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,299.78 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,107.17 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on June 2, 2025, with an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $25,277.89 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $35,332.72 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitive award, executed under firm fixed pricing with no set-aside designation, leverages AmerisourceBergen's established pharmaceutical distribution capabilities to support federal medical procurement needs. The delivery will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $11,453.04 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This is a firm fixed-price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 2, 2025. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements in open competition. This...
- The Defense Logistics Agency awarded a $3,354.92 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a pharmaceutical supply delivery to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $13,515.86 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical supply to support federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $5,307.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's facility in...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKA93Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,835.70 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 22, 2025, with completion scheduled for September 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the place of performance for this transaction. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 million through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities to support military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet diverse pharmaceutical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 9/22/25 |